期刊文献+

不同疗程四联疗法根除幽门螺杆菌的疗效观察 被引量:1

Study of 4-,5- and 7-day pantoprazole quadruple therapy regimens in the treatment of Helicobacter pylori infection
原文传递
导出
摘要 目的研究泮托拉唑短程四联4、5、7d疗法根除幽门螺杆菌(Hp)的疗效。方法166例经胃镜证实Hp阳性的重度胃炎患者随机分为泮托拉唑四联疗法4d组、5d组和7d组,均给予泮托拉唑40mg+枸橼酸铋钾220mg+克拉霉素250mg+阿莫西林1g,每日2次治疗,泮托拉唑疗程1周,枸橼酸铋钾疗程2周,克拉霉素、阿莫西林疗程在3组分别为4、5和7d。疗程结束4周后复查Hp,观察Hp根除率、症状缓解率及不良反应等。结果泮托拉唑四联疗法4、5和7d组Hp根除率分别为73.8%(45/61)、75.9%(41/54)和80.4%(41/51);疼痛缓解率分别为82.4%(42/51)、85.1%(40/47)和88,9%(40/45),各组之间比较差异均无统计学意义(均P〉0.05)。结论泮托拉唑四联短程疗法(4或5d)为安全、有效、符合药物经济学要求的根除Hp的方案。 Objective To compare the efficacy of pantoprazole based short-term quadruple regimens in the treatment of Helicobacter pylori ( H. pylori) infection for 4 days,5 days or 7days. Methods 166 patients with H. pylori associated severe gastritis were randomly divided into pantoprozole quadruple regimens of 4-day group ( n = 61 ) ,5-day group ( n =54) or 7-day group ( n = 51 ). The regimen was pantoprazole 40 mg,bismuth potassium citrate 220 mg,clarithromycin 250 mg and amoxicillin 1 g twice daily. The patients received pantoprazole for 1 week, bismuth potassium citrate for 2 weeks,clarithromycin and amoxicillin for 4 days,5 days or 7 days respectively. The H. pylori eradication and symptomatic relief was determinded by ^13 C-UBT at least 4 weeks after the therapy. Results The H. pylori eradication rates of 4-day,5-day or 7-day pantoprazole quadruple regimens were 73.8% (45/61) ,75. 9% (41/54) and 80.4% (41/51) respectively. The pain relief rates were 82, 4% (42/51) ,85.1% (40/47) and 88.9% ( 40/45 ) in 4-day,5-day and 7 day group. Conclusion The 4-day and 5- day pantoprazole based quadrual therapy is a shortterm, effective, safe and lower therapeuticcost regimen for H. pylori eradication.
出处 《中国综合临床》 北大核心 2008年第8期782-784,共3页 Clinical Medicine of China
关键词 胃炎 幽门螺杆菌 泮托拉唑 短程四联疗法 Gastritis Helicobater pylori Pantoprazole Short-term quadrual regimen
  • 相关文献

参考文献14

二级参考文献35

  • 1汪雪峰,王克霞,李朝品.淮南地区幽门螺杆菌感染情况及其相关疾病的调查[J].热带病与寄生虫学,2004,2(2):86-89. 被引量:6
  • 2Malfertheiner P, Megraud F, O'Morain C, et al. European Helicobacter Pylori Study Group(EHPSG). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther, 2002,16:167-180.
  • 3Comet R,Calvet X,Navarro M,et al.Seven-day therapy with omeprazole,clarithromycin and amoxicillin for treatment of Helicobacter pylori infection[J].Gastroenterol Hepatol,1998,21(2):81-83.
  • 4Calvet X,Lopez-Lorente M,Cubells M,et al.Two-week dual vs.One-week triple therapy for cure of Helicobacter pylori infection in primary care:a multicentre,randomized trial[J].Aliment Pharmacol Ther,1999,13(6)∶781-786.
  • 5Lamouliatte H,Cayla R.Helicobacter eradication with a one week triple therapy:meta-analysis of french studies (Abstract)[J].Gut,1998,43(Suppl 2):a84.
  • 6Laine L,Frantz JE,Baker A,et al.A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori[J].Aliment Pharmacol Ther,1997,11(5):913-917.
  • 7Pipkin GA,Williamson R,Wood JR.One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori[J].Aliment Pharmacol Ther,1998,12(9):823-837.
  • 8Malfertheiner P,Megraud F,O'morain C,et al.Current concepts in the management of Helicobacter pylori infection,The Maastricht 2-2000 Consensus Report[J].Aliment Pharmacol Ther,2002,16(2):167-180.
  • 9De Boer WA,Drissen WMH,Jansz AR,et al.Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients:results of a randomized prospective simgle-center study[J].Eur J Gastroenterol Hepatol,1995,7(12)∶1189-1194.
  • 10De Boer WA,van Etten RJ,Coremans A,et al.Two-day ''weekend'' lansoprazole quadruple therapy for Helicobacter pylori infection[J].Aliment Pharmacol Ther,1998,12(1):77-81.

共引文献483

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部